Literature DB >> 7563208

How does the MRP/GS-X pump export doxorubicin?

T Ishikawa, K Akimaru, M T Kuo, W Priebe, M Suzuki.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7563208     DOI: 10.1093/jnci/87.21.1639

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  5 in total

1.  ATP-dependent uptake of natural product cytotoxic drugs by membrane vesicles establishes MRP as a broad specificity transporter.

Authors:  S Paul; L M Breuninger; K D Tew; H Shen; G D Kruh
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

2.  ATP- and glutathione-dependent transport of chemotherapeutic drugs by the multidrug resistance protein MRP1.

Authors:  J Renes; E G de Vries; E F Nienhuis; P L Jansen; M Müller
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

3.  Induction of MRP/GS-X pump and cellular resistance to anticancer prostaglandins.

Authors:  K Akimaru; M T Kuo; K Furuta; M Suzuki; R Noyori; T Ishikawa
Journal:  Cytotechnology       Date:  1996       Impact factor: 2.058

4.  Comparative evaluation by semiquantitative reverse transcriptase polymerase chain reaction of MDR1, MRP and GSTp gene expression in breast carcinomas.

Authors:  R Lacave; F Coulet; S Ricci; E Touboul; A Flahault; J G Rateau; D Cesari; J P Lefranc; J F Bernaudin
Journal:  Br J Cancer       Date:  1998-03       Impact factor: 7.640

5.  Drug resistance features and S-phase fraction as possible determinants for drug response in a panel of human ovarian cancer xenografts.

Authors:  G M Kolfschoten; T M Hulscher; H M Pinedo; E Boven
Journal:  Br J Cancer       Date:  2000-10       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.